Abstract
A series of heterocycle-linked constrained phenylbenzyl amides were found to be TRPV1 antagonists with promising in vivo profiles. In particular, one of the analogues containing a furan linker exhibited excellent TRPV1 antagonistic activity and in vivo analgesic efficacy. In addition, the binding modes of dibenzyl thiourea, benzylphenethyl amide, and furan-linked phenylbenzyl amide were examined by using the flexible docking study within the rTRPV1 homology model. Flexibility not desired: A series of heterocycle-linked constrained phenylbenzyl amides were found to be TRPV1 antagonists with promising in vivo profiles. In particular, one of the analogues containing a furan linker exhibited excellent TRPV1 antagonistic activity and in vivo analgesic efficacy. In addition, the binding modes of dibenzyl thiourea, benzylphenethyl amide, and furan-linked phenylbenzyl amide were examined by using the flexible docking study within the rTRPV1 homology model.
| Original language | English |
|---|---|
| Pages (from-to) | 400-409 |
| Number of pages | 10 |
| Journal | Chemistry - An Asian Journal |
| Volume | 8 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2013 |
Keywords
- TRVP1
- antagonists
- ligand design
- medicinal chemistry
- molecular modeling